Fidelity Investments’s Imperva, Inc. IMPV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-12
Closed -$1K 4511
2018
Q4
$1K Hold
12
﹤0.01% 3478
2018
Q3
$1K Buy
+12
New +$581 ﹤0.01% 3494
2017
Q3
Sell
-170,561
Closed -$8.16M 2673
2017
Q2
$8.16M Sell
170,561
-122,048
-42% -$5.69M ﹤0.01% 2015
2017
Q1
$12M Sell
292,609
-91,154
-24% -$3.8M ﹤0.01% 1898
2016
Q4
$14.7M Sell
383,763
-1,365,273
-78% -$55.4M ﹤0.01% 1809
2016
Q3
$93.9M Sell
1,749,036
-1,015,513
-37% -$47.1M 0.01% 1010
2016
Q2
$119M Sell
2,764,549
-335,022
-11% -$14.1M 0.02% 897
2016
Q1
$157M Buy
3,099,571
+841,965
+37% +$40.5M 0.02% 768
2015
Q4
$143M Sell
2,257,606
-1,153,503
-34% -$78.5M 0.02% 814
2015
Q3
$223M Sell
3,411,109
-309,218
-8% -$20.5M 0.03% 581
2015
Q2
$252M Buy
3,720,327
+313,558
+9% +$17.3M 0.03% 578
2015
Q1
$145M Buy
3,406,769
+329,641
+11% +$14.7M 0.02% 854
2014
Q4
$152M Sell
3,077,128
-897,068
-23% -$35.9M 0.02% 798
2014
Q3
$114M Buy
3,974,196
+29,220
+0.7% +$793K 0.02% 909
2014
Q2
$103M Buy
3,944,976
+2,862,921
+265% +$73.9M 0.01% 984
2014
Q1
$60.3M Buy
+1,082,055
New +$62.3M 0.01% 1234
2013
Q4
Sell
-52,600
Closed -$2.21M 2727
2013
Q3
$2.21M Sell
52,600
-13,600
-21% -$648K ﹤0.01% 2327
2013
Q2
$2.98M Buy
+66,200
New +$2.6M ﹤0.01% 2243

Fidelity Investments's IMPV Position: Q1 2019 in Review

Fidelity Investments sold out of Imperva, Inc. (IMPV) in Q1 2019, closing a stake of 12 shares — an estimated $1K sold.

Fidelity Investments first reported a position in IMPV in Q2 2013 and held it in 18 quarters. The position peaked at $252M in Q2 2015. 0 funds tracked by Wall St. Rank hold IMPV as of Q1 2019.

  • Fidelity Investments reported no remaining Imperva, Inc. position as of Q1 2019 after selling out during the quarter.
  • Fidelity Investments sold 12 Imperva, Inc. shares in Q1 2019, an estimated $1K.
  • Fidelity Investments first reported a position in Imperva, Inc. in Q2 2013 and held it in 18 quarters.
  • Fidelity Investments's Imperva, Inc. position peaked at $252M in Q2 2015.
  • 0 funds tracked by Wall St. Rank held Imperva, Inc. as of Q1 2019.

Based on Fidelity Investments's 13F filing for Q1 2019, filed 13 May 2019.